Human Genetic Variation Alters Anthrax Toxin Sensitivity
Martchenko, Candille et al., PNAS
Researchers at Stanford University School of Medicine show that genetic variation affecting capillary morphogenesis gene 2, or CMG2, dramatically alters toxin sensitivity in humans. In its analysis, the team reports on "a CMG2 single-nucleotide polymorphism occurring frequently in African and European populations [that they found] independently altered toxin uptake." The group goes on to suggest "testing of genomically characterized human cell populations may offer a broadly useful strategy for elucidating effects of genetic variation on infectious disease susceptibility."
HealthLinx Releases Data Suggesting Usefulness of Biomarker for Detection of Prostate Cancer
In a study using a well-defined set of 30 prostate cancer plasma samples and 14 male controls, researchers detected the biomarker in three of the 14 control samples and in 27 of the 30 prostate cancer samples.
New to GenomeWeb? Register quickly here.